'I called NHS dentists for 7 years but couldn't get in, so pulled my teeth out'
A desperate pensioner pulled out her last three teeth because she was unable to get an NHS dentist.
Linda Colla, 76, had been calling around practices for seven years trying to get an appointment but has just been stuck on waiting lists. The Mirror visited Linda in Devon as part of a series of special reports from one of Britain's worst dentistry deserts. The British Dental Association has demanded that Labour urgently reforms the NHS dental contract to end the 'horror show'. Local MP Caroline Voaden told the Mirror that not a single dentist in South Devon is now taking on new NHS patients.
Linda, a retired charity manager who receives pension credit, said: 'My gums were all inflamed and were so painful I could only eat baby food and soup. I couldn't eat anything solid. In the end I just pulled my teeth out. I just kept wiggling it and wiggling it until it came out. When I went through childbirth with my daughter they always told me I had a high pain threshold.'
Without the three teeth to anchor it, Linda's lower denture plate wouldn't fit. She eventually found the money to pay a private dentist £200 to fit a new one. The mother-of-two said: 'My plate had to be adapted to have the three teeth put in but that cost me £200 which was my week's pension gone in one fell swoop.
'I'm a pensioner and I should have free NHS dental treatment but I can't get it, despite all the years I've paid into the NHS through taxes and National Insurance contributions.
'Let's face it, if you paid into an insurance company and then when you needed them they didn't deliver then there would be hell to pay. But that is what the government is doing.
READ MORE: 'I pulled my own tooth out with a pipe wrench because of the unbearable toothache'
'Now I'm in a situation now where at the moment my dentures aren't too bad but at some point I've either got to have them realigned or replaced. I'm going to have to find £1,500 for dentures and I'm on pension credit - one of the poorest people in the country so they tell me - I can't afford that. And I shouldn't have to go into debt to see a dentist.'
A number of different question responses in last year's GP Patient Survey suggested Devon is one of the places in the country where it is hardest to get an appointment with an NHS dentist.
Linda said: 'It's the most awful thing because your face is what you present to people. When you lose your teeth, you're losing a heck of a lot of self-confidence. My self-confidence went down the plughole. So I do worry for all the children that are losing their teeth. When they start off with bad oral health that is going to dog them for the rest of their lives.'
After a decade of real terms funding cuts under the Tories the £3 billion NHS dental budget for England is now only enough to treat around half of the population.
Linda said: 'There's not the budget for dentists to be able to take on more on the NHS, this is what I was told. They can't work for nothing. I must have called about a dozen NHS dentists and I'm willing to travel 20 miles but I can't get in anywhere. I could afford to go private I'd get a dentist tomorrow.'
Caroline Voaden, Lib Dem MP for South Devon, told the Mirror: 'Scarily, stories like Linda's are not rare – with not a single dentist in South Devon taking on NHS patients. Urgent action is needed to attract and reward dentists who practise in less-served areas.'
The British Dental Association warned the Public Accounts Committee earlier this year that the Treasury has become reliant on practices delivering care at a loss - fuelling an exodus of NHS dentists into lucrative private work.
Caroline Voaden MP added: 'Remuneration is one part of this, but we should also explore a contract that gives dentists greater flexibility, reduces red tape, and promotes the kind of work-life balance that mirrors what they find in the private sector.
'The sad truth is that this Government has been in office for a year now and has often spoken about reforming the NHS dental contract. But in the same period, South Devon has lost three dental surgeries, and more are on the brink. While the Government weighs its options, this crisis is deepening.'
Last week the Government published its Ten Year Health Plan which pledged that "by 2035 the NHS dental system will be transformed" - but the British Dental Association insists contract reform must happen much sooner.
READ MORE: Keir Starmer's plan to 'rewire' NHS explained – why you won't have to go to hospital
The professional body estimates a typical practice loses over £40 delivering a set of NHS dentures and £7 for every new patient exam. A Parliamentary report by the Health Select Committee has described the state of NHS dentistry as "unacceptable in the 21st century".
The NHS contract effectively sets quotas on the maximum number of NHS patients a dentist can see as it caps the number of procedures they can perform each year.
BDA chair Eddie Crouch said: 'The crisis in NHS dentistry was made in Westminster. A failed contract has left patients taking matters into their own hands, or flying abroad for care that should be available in their own backyard. We can end this horror show, but we need to see real urgency and ambition.'
Dentists for All campaign
Save NHS Dentistry petition
Sign our petition to save NHS dentistry and make it fit for the 21st century
Our 3 demands
Everyone should have access to an NHS dentist
More than 12 million people were unable to access NHS dental care last year – more than 1 in 4 adults in England. At the same time 90% of dental practices are no longer accepting new NHS adult patients. Data from the House of Commons Library showed 40% of children didn't have their recommended annual check-up last year.
Restore funding for dental services and recruit more NHS dentists
The UK spends the smallest proportion of its heath budget on dental care of any European nation. Government spending on dental services in England was cut by a quarter in real terms between 2010 and 2020. The number of NHS dentists is down by more than 500 to 24,151 since the pandemic.
Change the contracts
A Parliamentary report by the Health Select Committee has branded the current NHS dentists' contracts as 'not fit for purpose' and described the state of the service as "unacceptable in the 21st century". The system effectively sets quotas on the maximum number of NHS patients a dentist can see as it caps the number of procedures they can perform each year. Dentists also get paid the same for delivering three or 20 fillings, often leaving them out of pocket. The system should be changed so it enables dentists to treat on the basis of patient need.
Have you had to resort to drastic measures because you couldn't access an NHS dentist? Are you a parent struggling to get an appointment for a child? Email martin.bagot@mirror.co.uk or call 0800 282591
The Government is rolling out 700,000 extra emergency dental appointments and bringing in supervising toothbrushing for three to five year olds in the most deprived areas of the country.
It is currently in negotiations with the British Dental Association about reforming the NHS dental contract.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
South Wales Guardian
25 minutes ago
- South Wales Guardian
‘Groundbreaking' drug could slow down progression of type 1 diabetes
Teplizumab, which is already approved in the US, trains the immune system to stop attacking pancreatic cells, delaying the need for insulin by an average of three years. With type 1 diabetes, the immune system attacks insulin-producing cells in the pancreas, meaning blood sugar levels are no longer regulated by the body. If blood sugar is too high or low, it can cause serious health problems and even death. People with type 1 therefore need daily insulin. Dentist and mother-of-two, Hannah Robinson, from Devon, is the first adult in the UK to try the drug in the hope it can delay the condition. She is having treatment at the Royal Devon University Healthcare NHS Foundation Trust after discovering during pregnancy she was in the early stages of developing type 1. A handful of people are being given the medicine on a case-by-case basis while it is reviewed for wider use on the NHS. The 36-year-old said: 'For me, this new drug offers more freedom and the chance to focus on my health before I have to start thinking differently and managing life as somebody needing daily insulin. 'This isn't just about what I eat or monitoring my glucose, it is also about having more control and not feeling defined by my condition. 'This treatment could potentially pave the way for a future cure for type 1 diabetes, which is incredible. I feel very lucky to be part of this.' The new drug teplizumab must be given at the earliest stage of the disease to be effective. Dr Nick Thomas, diabetes consultant and academic clinical lecturer at the University of Exeter, said: 'This new treatment represents a really exciting shift in how we manage type 1 diabetes. 'For the first time ever, we will be able to provide targeted treatment early enough in the process to alter the underlying immune process, aiming to slow down how quickly people need insulin. 'Approximately half of all type 1 diabetes cases develop in adulthood, and Hannah will be the first adult in the UK to receive this treatment. 'My hope is that in the future, we may be able to stop people with early type 1 diabetes from needing insulin at all.' Experts at the Royal Devon and the University of Exeter are using genetics and other testing to spot people at high risk of developing type 1 diabetes. The hope is more people could be offered the drug to delay type 1. Dr Lucy Chambers, head of research impact and communications at Diabetes UK, said: 'For people in the early stages of type 1 diabetes, teplizumab offers a groundbreaking opportunity to buy them precious extra years insulin-free. 'Right now, it's only available in research settings – and while the excitement is real, urgent work is still needed to ensure it reaches everyone who could benefit. 'That means securing a UK licence for teplizumab, establishing national screening programmes to identify people with early-stage type 1 diabetes before symptoms appear, and preparing the NHS to deliver this treatment at scale. 'Diabetes UK is proud to be at the forefront of these efforts – funding pioneering research and working closely with the NHS towards a future where immunotherapies become the first-line treatment for tackling the autoimmune attack at the root of type 1 diabetes.' Professor Richard Oram, consultant physician at the Royal Devon and professor at the University of Exeter, said: 'Excitingly, teplizumab is the first drug with the potential to delay type 1 diabetes, but needs to be given before clinical diagnosis due to high blood glucose. 'It is really important to find new and improved approaches for identifying individuals at elevated risk.'
South Wales Guardian
25 minutes ago
- South Wales Guardian
Medicine shortages put patients at risk, MPs and peers warn
A new report from the All-Party Parliamentary Group (APPG) on pharmacy called for urgent action to ensure shortages do not become the 'new normal'. It also highlights the impact that shortages are having on patients with the likes of ADHD (attention deficit hyperactivity disorder), menopause and diabetes. Writing in the report, Steve Race, chairman of the APPG on pharmacy, said many MPs 'have received a growing volume of correspondence from constituents who are understandably anxious about the availability of their medicines'. 'Whether it is a parent unable to access antibiotics for a sick child, an elderly patient facing delays in obtaining life-sustaining medication, or a pharmacist overwhelmed by the need to source alternatives, the human impact is both visible and deeply troubling,' he wrote. The report said that while medicine shortages are 'not a new phenomenon', they have 'become increasingly severe, persistent, and disruptive' in recent years – leading to consequences for patients, staff and the wider health service. Mr Race said: 'Medicines shortages have moved from isolated incidents to a chronic structural challenge for both the NHS and pharmacy sector. 'As Government continues to recognise and invest in the expanded clinical role of community pharmacy, we must ensure the medicines supply chain underpinning that care is equally robust, resilient and patient-focused. 'Pharmacy is central to NHS recovery and transformation, but frontline teams cannot safely expand clinical services while daily supply disruptions continue to impact the health of patients.' The findings also highlight how shortages severely impact patients with conditions like ADHD, menopause and diabetes. More than nine in 10 pharmacists, GPs and prescribers told an APPG survey ADHD medicines had been affected by shortages. Around three quarters (76%) said HRT and diabetes drugs had been affected, while 44% said antibiotics. One patient with ADHD told the inquiry they had been self-medicating with cannabis due to an ongoing shortage of methylphenidate. The report said: 'These shortages are having a significant impact on patients' ability to access treatments and in some cases are having serious impact on patients' health and well-being.' Mr Race added: 'Medicines security must be treated as a core component of NHS planning, alongside funding, workforce and digital infrastructure. 'Failure to act risks further undermining patient care and destabilising a community pharmacy sector that millions depend upon.' The APPG has laid out a number of recommendations, which includes a number of measures to better support patients. People impacted by shortages, particularly those with chronic conditions, struggle to find information on out of stock drugs, leading to 'frustration, dangerous delays in care, and unnecessary anxiety and harm', it said. It also welcomed work being carried out by the Department of Health and Social Care to potentially change pharmacist prescribing protocols to allow pharmacists to make dose and formulation changes during shortages. Elsewhere, the inquiry found more than eight in 10 pharmacists face daily shortages, with many spending hours every day finding alternative treatment and communicating with distressed patients. One told the APPG they are 'constantly firefighting'. Reacting to the report, Henry Gregg, chief executive of the National Pharmacy Association (NPA), said: 'Pharmacy teams are under enormous pressure but are forced to spend hours hunting down stock for distressed and frustrated patients. 'It is particularly frustrating for pharmacists to be unable to meet a clear need when they have a perfectly safe and effective solution in their pharmacy already. 'MPs are right that it is madness to send someone back to their GP to get a prescription changed, and it risks a patient either delaying taking vital medication or forgoing it altogether, which poses a clear risk to patient safety. 'As the APPG says, the Government must allow pharmacists – who are highly trained health care practitioners – to use their professional judgment to supply an appropriate alternative medication when the prescribed version is unavailable.' A Department of Health and Social Care spokesperson said: 'This government inherited ongoing global supply problems, but we have robust measures in place to mitigate disruption for patients. 'We are working to build the resilience of medicine supply chains and prevent future disruption as we get the NHS back on its feet. 'We have recently agreed an extra £617 million of funding over two years with Community Pharmacy England to support the sector and provide patients with more services closer to home as part of our 10 Year Health Plan.'
North Wales Chronicle
33 minutes ago
- North Wales Chronicle
Medicine shortages put patients at risk, MPs and peers warn
A new report from the All-Party Parliamentary Group (APPG) on pharmacy called for urgent action to ensure shortages do not become the 'new normal'. It also highlights the impact that shortages are having on patients with the likes of ADHD (attention deficit hyperactivity disorder), menopause and diabetes. Writing in the report, Steve Race, chairman of the APPG on pharmacy, said many MPs 'have received a growing volume of correspondence from constituents who are understandably anxious about the availability of their medicines'. 'Whether it is a parent unable to access antibiotics for a sick child, an elderly patient facing delays in obtaining life-sustaining medication, or a pharmacist overwhelmed by the need to source alternatives, the human impact is both visible and deeply troubling,' he wrote. The report said that while medicine shortages are 'not a new phenomenon', they have 'become increasingly severe, persistent, and disruptive' in recent years – leading to consequences for patients, staff and the wider health service. Mr Race said: 'Medicines shortages have moved from isolated incidents to a chronic structural challenge for both the NHS and pharmacy sector. 'As Government continues to recognise and invest in the expanded clinical role of community pharmacy, we must ensure the medicines supply chain underpinning that care is equally robust, resilient and patient-focused. 'Pharmacy is central to NHS recovery and transformation, but frontline teams cannot safely expand clinical services while daily supply disruptions continue to impact the health of patients.' The findings also highlight how shortages severely impact patients with conditions like ADHD, menopause and diabetes. More than nine in 10 pharmacists, GPs and prescribers told an APPG survey ADHD medicines had been affected by shortages. Around three quarters (76%) said HRT and diabetes drugs had been affected, while 44% said antibiotics. One patient with ADHD told the inquiry they had been self-medicating with cannabis due to an ongoing shortage of methylphenidate. The report said: 'These shortages are having a significant impact on patients' ability to access treatments and in some cases are having serious impact on patients' health and well-being.' Mr Race added: 'Medicines security must be treated as a core component of NHS planning, alongside funding, workforce and digital infrastructure. 'Failure to act risks further undermining patient care and destabilising a community pharmacy sector that millions depend upon.' The APPG has laid out a number of recommendations, which includes a number of measures to better support patients. People impacted by shortages, particularly those with chronic conditions, struggle to find information on out of stock drugs, leading to 'frustration, dangerous delays in care, and unnecessary anxiety and harm', it said. It also welcomed work being carried out by the Department of Health and Social Care to potentially change pharmacist prescribing protocols to allow pharmacists to make dose and formulation changes during shortages. Elsewhere, the inquiry found more than eight in 10 pharmacists face daily shortages, with many spending hours every day finding alternative treatment and communicating with distressed patients. One told the APPG they are 'constantly firefighting'. Reacting to the report, Henry Gregg, chief executive of the National Pharmacy Association (NPA), said: 'Pharmacy teams are under enormous pressure but are forced to spend hours hunting down stock for distressed and frustrated patients. 'It is particularly frustrating for pharmacists to be unable to meet a clear need when they have a perfectly safe and effective solution in their pharmacy already. 'MPs are right that it is madness to send someone back to their GP to get a prescription changed, and it risks a patient either delaying taking vital medication or forgoing it altogether, which poses a clear risk to patient safety. 'As the APPG says, the Government must allow pharmacists – who are highly trained health care practitioners – to use their professional judgment to supply an appropriate alternative medication when the prescribed version is unavailable.' A Department of Health and Social Care spokesperson said: 'This government inherited ongoing global supply problems, but we have robust measures in place to mitigate disruption for patients. 'We are working to build the resilience of medicine supply chains and prevent future disruption as we get the NHS back on its feet. 'We have recently agreed an extra £617 million of funding over two years with Community Pharmacy England to support the sector and provide patients with more services closer to home as part of our 10 Year Health Plan.'
